Dexcom (DXCM) Payables (2011 - 2025)

Dexcom's (DXCM) quarterly Payables came in at $1.2 billion in Q3 2025, little changed on a QoQ basis from $1.2 billion in Q2 2025.

Dexcom (DXCM) Payables (2011 - 2025) Analysis & Trends

Dexcom (DXCM) has 6 years of Payables data on file, last reported at $1.2 billion in Q3 2025.

  • On a quarterly basis, Payables changed N/A year-over-year to $1.2 billion in Q3 2025; TTM through Sep 2025 was $1.2 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 billion, changed N/A from the prior year.
  • Payables for Q3 2025 stood at $1.2 billion, roughly flat from $1.2 billion in the prior quarter.
  • Over the last five years, Payables for DXCM reached as high as $1.2 billion in Q3 2025 and fell as low as $124.2 million in Q3 2023.
  • Historically, Payables has averaged $908.3 million across 4 years, with a median of $989.1 million in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 5.78 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 1.93 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 2.64 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 181.10 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 2.39 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 3.42 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 1.18 Bn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 457.70 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 1.21 Bn
Jun 30, 2025 1.21 Bn
Mar 31, 2025 1.21 Bn
Dec 31, 2024 1.20 Bn
Sep 30, 2023 124.20 Mn
Jun 30, 2023 773.80 Mn
Mar 31, 2023 773.20 Mn
Dec 31, 2022 772.60 Mn
Dec 31, 2012 3.90 Mn
Sep 30, 2012 3.80 Mn
Jun 30, 2012 2.02 Mn
Dec 31, 2011 2.80 Mn